Plus   Neg

Best Buy Climbs Off Worst Levels But Remains Firmly Negative

Shares of Best Buy Co., Inc. (BBY) have climbed off their worst levels of the day but remain firmly negative in afternoon trading on Monday. After hitting its lowest intraday level in well over a year, Best Buy is currently down by 3.4 percent.

Best Buy initially came under pressure after Bank of America Merrill Lynch downgraded its rating on the consumer electronic retailer's stock to Underperform from Neutral and lowered its price target to $50 per share from $30 per share.

BAML analyst Curtis Nagle cited "deceleration in industry growth trends and continued caution on key product categories such as TVs, Apple products and gaming."

For comments and feedback contact: editorial@rttnews.com

Business News

Editors Pick
MillerCoors LLC has filed a lawsuit against Anheuser-Busch Companies LLC, part of Anheuser-Busch InBev, alleging that Anheuser-Busch's ad campaigns associating MillerCoors' products, Miller Lite and Coor Light, with corn syrup is "false and misleading." During the Super Bowl, ABInBev ran an advertising campaign that mocked Miller Lite and Coors Light use corn syrup in brewing. Shares of Biogen Inc. are falling almost 28 percent in Thursday's trading after the company and Japanese drugmaker Eisai Co. said they will discontinue two late-stage trials for their experimental Alzheimer's drug, Aducanumab. The two Phase 3 trials, ENGAGE and EMERGE, are multi-center, randomized, double-blind, placebo-controlled, parallel-group studies designed to evaluate Aducanumab. The European Union on Wednesday ordered Alphabet Inc.'s Google to pay an antitrust fine of 1.49 billion euros for abusing its dominant position in the online search advertising intermediation market by preventing competition. This is the third antitrust fine by the EU against Google and it represents 1.29 percent of the tech giant's turnover in 2018.
Follow RTT